Condition: Obesity · Type 2 Diabetes · Sponsor: Novo Nordisk A/S
This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive either CagriSema or semaglutide, and which treatment participants receive is decided by chance. CagriSema is a new study medicine being tested, while semaglutide is a medicine that doctors can already prescribe. The study will last for about 83 weeks
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Uni of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Cahaba Research | Pelham, Alabama, United States | Recruiting |
| Elligo Health Research Inc | Gilbert, Arizona, United States | Recruiting |
| Velocity Clinical Research-Phoenix | Phoenix, Arizona, United States | Recruiting |
| Arkansas Clinical Research | Little Rock, Arkansas, United States | Recruiting |
| Woodland Int. Research Group | Little Rock, Arkansas, United States | Recruiting |
| Headlands Research California, LLC | Escondido, California, United States | Recruiting |
| Neighborhood Healthcare | Escondido, California, United States | Recruiting |
| Diabetes & Endocrine Specialists - La Mesa | La Mesa, California, United States | Recruiting |
| Clinical Trials Research_Sacramento | Lincoln, California, United States | Recruiting |
| Loma Linda University Faculty Medical Clinics | Loma Linda, California, United States | Recruiting |
| Pacific Clinical Studies | Los Alamitos, California, United States | Recruiting |
+ 291 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07564414